Quest PharmaTech Inc.
QPTFF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $1 | $0 | $0 |
| G&A Expenses | $0 | $1 | $0 | $1 |
| SG&A Expenses | $0 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | -$0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$1 | -$2 | -$64 | -$84 |
| Pre-Tax Income | -$2 | -$3 | -$65 | -$85 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$3 | -$65 | -$85 |
| % Margin | – | – | – | – |
| EPS | -0.011 | -0.018 | -0.39 | -0.51 |
| % Growth | 40.4% | 95.4% | 23.5% | – |
| EPS Diluted | -0.011 | -0.018 | -0.39 | -0.51 |
| Weighted Avg Shares Out | 164 | 169 | 168 | 168 |
| Weighted Avg Shares Out Dil | 169 | 169 | 168 | 168 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |